Advanced therapies in pulmonary arterial hypertension and congenital heart disease in people with Down syndrome
Abstract Background Management of patients with pulmonary arterial hypertension associated with congenital heart disease and trisomy 21 is complex due to uncertainty over the best first-line agent to use for treatment, and the outcome measures for assessing response to therapy. There are also ethica...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-12-01
|
| Series: | Journal of Congenital Cardiology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40949-020-00051-x |